| 1. |
Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Kurosawa M, Kitaichi N, Takeno M, Kaneko T, Mizuki N: The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey. Mod Rheumatol, 30: 708-714, 2020. |
| 2. |
Teranishi S, Kobayashi N, Aoki A, Katakura S, Yamamoto M, Koizumi H, Kudo M, Kaneko T: Reproducibility of the T-SPOT.TB test for screening Mycobacterium tuberculosis infection in Japan. J Infect Chemother, 26: 194-198, 2020. |
| 3. |
Ueki Y, Oshikata C, Asai Y, Kaneko T, Tsurikisawa N: Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother. Intern Med, 59: 991-995, 2020. |
| 4. |
Teranishi S, Kobayashi N, Katakura S, Kamimaki C, Kubo S, Shibata Y, Yamamoto M, Kudo M, Piao H, Kaneko T: Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancer. Thorac Cancer, 11: 983-992, 2020. |
| 5. |
Murohashi K, Hara Y, Aoki A, Matsumura M, Kataoka T, Okudela K, Kaneko T: Diffuse alveolar hemorrhage complicating acute exacerbation of IPF. Respir Med Case Rep, 29: 101022, 2020. |
| 6. |
Shibata Y, Kobayashi N, Sato T, Nakashima K, Kaneko T: The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer. Thorac Cancer, 11: 1258-1264, 2020. |
| 7. |
Horita N, Kaneko T: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial. Am J Respir Crit Care Med, 202: 150-151, 2020. |
| 8. |
Inoue M, Enomoto T, Kawamoto M, Mikami N, Kuribayashi H, Saeki N: SMARCA4-deficient lung tumour that presented with haemoptysis and progressed rapidly. Respirol Case Rep, 8: e00656, 2020. |
| 9. |
Matsumoto S, Watanabe K, Kobayashi N, Irie K, Yamanaka S, Kaneko T: Pembrolizumab-induced secondary sclerosing cholangitis in a non-small cell lung cancer patient. Respirol Case Rep, 8: e00560, 2020. |
| 10. |
Sakono T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Ito T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Horita N, Ota M, Mizuki N: Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population. PLoS One, 15: e0233464, 2020. |
| 11. |
Kobayashi N, Hashimoto H, Kamimaki C, Nagasawa R, Tanaka K, Kubo S, Katakura S, Chen H, Hirama N, Ushio R, Aoki A, Nakashima K, Teranishi S, Manabe S, Watanabe H, Horita N, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T: Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial. Thorac Cancer, 11: 2125-2129, 2020. |
| 12. |
Ito H, Ito M, Kakuta Y, Kaneko T, Okudera K, Ogura T: Multisystem Langerhans cell histiocytosis in an adult non-smoker treated with steroid therapy. Respirol Case Rep, 8: e00603, 2020. |
| 13. |
Kubota M, Moriguchi S, Takahata K, Nakajima S, Horita N: Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Schizophr Res, 222:122-132, 2020. |
| 14. |
Ebina-Shibuya R, Horita N, Namkoong H, Kaneko T: National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19. Respirology, 25: 898-899, 2020. |
| 15. |
Kubota M, Moriguchi S, Takahata K, Nakajima S, Horita N: Treatment effects on neurometabolite levels in schizophrenia: A meta-analysis dataset of proton magnetic resonance spectroscopy. Data Brief, 31: 105862, 2020. |
| 16. |
Manabe S, Kasajima R, Murakami S, Miyagi Y, Yokose T, Kondo T, Saito H, Ito H, Kaneko T, Yamada K: Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next-generation sequencing technique. Thorac Cancer, 11: 2262-2269, 2020. |
| 17. |
Kubo S, Kobayashi N, Somekawa K, Hirata M, Kamimaki C, Aiko H, Katakura S, Teranishi S, Watanabe K, Hara Y, Yamamoto M, Kudo M, Kaneko T: Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor. Anticancer Res, 40: 3889-3896, 2020. |
| 18. |
Meguro A, Ishihara M, Petrek M, Yamamoto K, Takeuchi M, Mrazek F, Kolek V, Benicka A, Yamane T, Shibuya E, Yoshino A, Isomoto A, Ota M, Yatsu K, Shijubo N, Nagai S, Yamaguchi E, Yamaguchi T, Namba K, Kaburaki T, Takase H, Morimoto SI, Hori J, Kono K, Goto H, Suda T, Ikushima S, Ando Y, Takenaka S, Takeuchi M, Yuasa T, Sugisaki K, Ohguro N, Hiraoka M, Kitaichi N, Sugiyama Y, Horita N, Asukata Y, Kawagoe T, Kimura I, Ishido M, Inoko H, Mochizuki M, Ohno S, Bahram S, Remmers EF, Kastner DL, Mizuki N: Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis. Commun Biol, 3:465, 2020. |
| 19. |
Shinagawa K, Oshikata C, Kaneko T, Tsurikisawa N: A case of lactoferrin-induced occupational asthma. J Allergy Clin Immunol Pract, 8: 3600-3602, 2020. |
| 20. |
Ebina-Shibuya R, Horita N, Namkoong H, Kaneko T: Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019. Clin Exp Vaccine Res, 9: 179-182, 2020. |
| 21. |
Murohashi K, Hagiwara E, Kitayama T, Yamaya T, Higa K, Sato Y, Otoshi R, Shintani R, Okabayashi H, Ikeda S, Niwa T, Nakazawa A, Oda T, Okuda R, Sekine A, Kitamura H, Baba T, Komatsu S, Iwasawa T, Kaneko T, Ogura T: Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases. Respir Investig, 58: 430-434, 2020. |
| 22. |
Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Manabe S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T: MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer. Thorac Cancer, 11:2975-2982, 2020. |
| 23. |
Chen H, Hara Y, Horita N, Saigusa Y, Hirai Y, Kaneko T: Declined Functional Status Prolonged Hospital Stay for Community-Acquired Pneumonia in Seniors. Clin Interv Aging, 15: 1513-1519, 2020. |
| 24. |
Nagasawa R, Hara Y, Miyazaki T, Murohashi K, Watanabe H, Kaneko T: An autopsy case of ventilator-associated tracheobronchitis caused by Corynebacterium species complicated with diffuse alveolar damage. Respir Med Case Rep, 31: 101208, 2020. |
| 25. |
Aoki A, Hara Y, Okudela K, Ishikawa Y, Doshita K, Hashimoto H, Nakashima K, Horita N, Kobayashi N, Kaneko T: Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax. Thorac Cancer, 11: 3407-3408, 2020. |
| 26. |
Chen H, Horita N, Ito K, Hara Y, Kobayashi N, Kaneko T: Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer. Transl Lung Cancer Res, 9: 1333-1342, 2020. |
| 27. |
Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T: Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan. Tuberculosis (Edinb), 125: 101992, 2020. |
| 28. |
Yumoto K, Sato T, Nakashima K, Namai F, Shigemori S, Shimosato T, Kaneko T: Nasally Administered Lactococcus lactis Secreting Heme Oxygenase-1 Attenuates Murine Emphysema. Antioxidants (Basel), 9: 1049, 2020. |
| 29. |
Watanabe K, Asai Y, Tsurikisawa N, Oshikata C, Kaneko T: Factors associated with pneumococcal vaccine uptake in elderly subjects referred to the respiratory department. Nagoya J Med Sci, 82: 469-476, 2020. |
| 30. |
Sasaki H, Hara Y, Taguri M, Fujikura Y, Murohashi K, Yagyu H, Kaneko T, Kawana A: Serum surfactant protein A as a surrogate biomarker of a negative heart sign among patients with interstitial lung disease. Nagoya J Med Sci, 82: 499-508, 2020. |
| 31. |
Yagyu H, Murohashi K, Hara Y, Saigusa Y, Aoki A, Kobayashi N, Kaneko T: Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease. J Thorac Dis, 12: 5774-5782, 2020. |
| 32. |
Nagasawa R, Hara Y, Murohashi K, Aoki A, Kobayashi N, Takagi S, Hashimoto S, Kawana A, Kaneko T: Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease. BMC Pulm Med, 20: 310, 2020. |
| 33. |
Horita N, Chen H, Kaneko T: Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer. Lancet Oncol, 21: e545, 2020. |
| 34. |
Chen H, Horita N, Ito K, Nagakura H, Hara Y, Kobayash N, Yamamoto M, Kudo M, Kaneko T: Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis. Ther Adv Med Oncol, 12: 1758835920965841, 2020. |
| 35. |
今泉和良, 山谷睦雄, 須田隆文, 礒部 威, 大平徹郎, 長内 忍, 川山智隆, 國近尚美, 佐野博幸, 柴田陽光, 新海正晴, 多賀谷悦子, 千葉弘文, 松本久子, 金子 猛, 日本呼吸器学会将来計画委員会: わが国の呼吸器臨床病理の現状と問題点 病理医のアンケート結果より. 日本呼吸器学会誌, 9: 311-318, 2020. |
| 36. |
伊藤俊輔, 大塚 葵, 石井宏志, 西平隆一, 平居義裕, 長澤 遼, 井上 玲, 陳 昊, 金子 猛: オシメルチニブにより著明な駆出率低下と心不全を認めた1例. 癌と化学療法, 47: 609-613, 2020. |
| 37. |
伊藤 悠, 伊藤 優, 原 悠, 髙橋良平, 角田幸雄, 金子 猛: 人工血管アスペルギルス感染症の1剖検例：文献レビューからの臨床像の考察. 日本呼吸器学会誌, 9: 23-27, 2020. |
| 38. |
伊藤 悠, 伊藤 優, 川島英俊, 山本健嗣, 金子 猛, 角田幸雄, 前原孝光: 転移性肺腫瘍の原発巣の鑑別を要し組織所見を経時的に観察し得た肺癌・直腸癌の重複癌の症例. 肺癌, 60: 109-114. |
| 39. |
加藤英明, 渡邊弘樹, 小林信明, 原 悠, 酒井和也, 中嶋賢人, 小川史洋, 佐野加代子, 山崎悦子, 宇宿修三, 田中伸子, 竹内一郎, 中島秀明, 金子 猛: SARS-CoV-2 PCR検査が長期陽性持続した新型コロナウイルス感染症(COVID-19)の2例. 感染症学雑誌, 94: 591-595, 2020. |
| 40. |
鎌田啓佑, 今野 哲, 金子 猛, 福永興壱, 長谷川好規, 横山彰仁: 新型コロナウイルス感染症診療における呼吸器内科医師の活動実態に関するアンケート調査結果. 日本呼吸器学会誌, 9: 233-238, 2020. |
| 41. |
張田佳代, 原 悠, 室橋光太, 長澤 遼, 奥寺康司, 金子 猛: 血清ヘムオキシゲナーゼ-1が病勢と連動したアビラテロン酢酸エステルによる薬剤性肺障害の1例. 日本呼吸器学会誌, 9: 141-146, 2020. |
Copyright(C) 横浜市立大学大学院医学研究科呼吸器病学 All Rights Reserved.